top of page

Captura de Pantalla 2024-01-10 a la(s) 12.03.40.png

Market
Highlights

The Three Biosimilars that MSD’s Top-Seller Keytruda is Already Facing

The Three Biosimilars that MSD’s Top-Seller Keytruda is Already Facing

The Three Biosimilars that MSD’s Top-Seller Keytruda is Already Facing

MSD's Keytruda already faces biosimilar erosion in four markets

Nov 17, 2024

bottom of page